This inventor holds 3 USPTO granted patents and 3 EPO patents. Top assignee: Ajinomoto Co., Ltd.. Active years: 2010-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2013
Title: Danila Vadimovich Zimenkov: Innovator in Genetic Engineering
Introduction
Danila Vadimovich Zimenkov is a prominent inventor based in Moscow, Russia. He has made significant contributions to the field of genetic engineering, particularly in the development of methods for constructing operons and controlling gene expression. With a total of 3 patents to his name, Zimenkov's work has the potential to impact various biotechnological applications.
Latest Patents
Zimenkov's latest patents include a method for constructing an operon containing translationally coupled genes. This invention provides a method for producing useful metabolites using bacteria that contain the coupled operons, as well as a method for monitoring gene expression. Another notable patent is an expression control sequence that regulates the expression of a target gene based on the intracellular concentration of an amino acid. This innovative approach allows for increased expression of the target gene in bacterial cells, enhancing the efficiency of genetic engineering processes.
Career Highlights
Zimenkov is currently employed at Ajinomoto Co., Ltd., where he continues to advance his research in genetic engineering. His work is characterized by a strong focus on practical applications that can lead to the development of new biotechnological solutions.
Collaborations
Some of his notable coworkers include Andrey Yurievich Gulevich and Sergei Vladimirovich Mashko. Their collaboration has contributed to the innovative research environment at Ajinomoto Co., Ltd.
Conclusion
Danila Vadimovich Zimenkov is a key figure in the field of genetic engineering, with a focus on operon construction and gene expression control. His contributions are paving the way for advancements in biotechnology and genetic research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
